Ellevest Inc’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Ellevest Inc’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-145	Closed	-$1K	–	1449
2020 Q3	$1K	Buy	+145	New	+$1.71K	﹤0.01%	1108

Other funds holding BLPH

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellevest Inc's BLPH Position: Q4 2020 in Review

Ellevest Inc sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2020, closing a stake of 145 shares — an estimated $1K sold.

Ellevest Inc first reported a position in BLPH in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 37 funds tracked by Wall St. Rank hold BLPH as of Q4 2020.

Ellevest Inc reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Ellevest Inc sold 145 Bellerophon Therapeutics, Inc. shares in Q4 2020, an estimated $1K.
Ellevest Inc first reported a position in Bellerophon Therapeutics, Inc. in Q3 2020 and held it in 1 quarter.
Ellevest Inc's Bellerophon Therapeutics, Inc. position peaked at $1K in Q3 2020.
37 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.